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Varicella zoster virus (VZV) can cause radicular pain in the absence of skin lesions; such cases are
referred to as zoster sine herpete (ZSH) and are usually diagnosed by using serological assays or poly-
merase chain reaction (PCR). An effort is underway to detect VZV DNA in novel specimens rather than
conventional samples (e.g., blood or cerebrospinal ﬂuid) for PCR. There are two reports that PCR analysis
in the exudate of the auricular skin can be a useful diagnostic tool for the diagnosis of ZSH in patients
presenting with cranial nerve paralysis without herpetic eruptions. Here, we report a case of ZSH
diagnosed by using PCR analysis of skin exudates in a patient who developed thoracic radicular pain. This
is believed to be the ﬁrst case of ZSH diagnosed using PCR analysis of skin exudate in a patient in whom
the cranial nerve was not involved.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Herpes zoster is characterized by pain and vesicular eruption on an
erythematous base in 1e3 dermatomes. However, varicella zoster
virus (VZV) reactivation can produce radicular pain without a rash
(zoster sine herpete, ZSH),1 making the diagnosis more difﬁcult for
physicians. In cases in which ZSH is suspected, virological conﬁr-
mation is needed. The conventional methods that use vesicle
samples (e.g., Tzanck smear, punch biopsy, and cell culture) are not
available for the diagnosis of ZSH. In addition, serological methods
that have been widely used for the diagnosis of herpes zoster are
not useful for an early diagnosis, because immunoglobulin (Ig)M
and IgA antibodies speciﬁc for acute VZV infection are only detec-
ted in about 60% of cases.2 Also, cross-reactions to herpes simplex
virus have been reported.3 Currently, when ZSH is suspected, blood
and cerebrospinal ﬂuid (CSF) examination for VZV DNA and anti-
VZV IgM and/or IgG antibody are available to conﬁrm the etiolog-
ical agent.4 However, CSF examination is too difﬁcult to perform iny have no ﬁnancial or non-
tter or materials discussed in
gy, Hallym University Sacred
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k).
iwanese Dermatological Associatiothe outpatient clinic, and VZV DNA has been detected in peripheral
blood mononuclear cells (PBMCs) in 16e20% of patients with her-
pes zoster.5,6 In addition, it has been revealed that VZV DNAwas not
detected in PBMCs from patients with ZSH.7 As a result, other
methods to diagnose ZSH have been attempted. Here, we report a
case of ZSH diagnosed by performing polymerase chain reaction
(PCR) analysis of skin exudate in a patient who developed thoracic
dermatomal distribution pain that had not been reported.
Case report
A 37-year-old woman was transferred to our dermatology depart-
ment from the orthopedic department because the orthopedist
could not ﬁnd the cause of her pain, even after analysis of thor-
acolumbar spine magnetic resonance imaging, and symptomatic
treatment with a painkiller was not effective. The patient com-
plained of burning pain that developed 2 weeks previously on her
right trunk and back. Concomitantly, she presented with cutaneous
lesions that developed on the right side of the back while using the
pain relief patch 5 days previously. Past history and family history
were unremarkable. On physical examination, several pinhead-
sized papules and pustules were localized to the application site
of the pain relief patch on the right side of the back (Figure 1). The
patient’s pain radiated to the right T7e8 dermatomes. To rule out
medical disease that may be the cause of the trunk and back pain,
laboratory studies, including complete blood cell count withn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Several pinhead-sized papules and pustules were localized to the application
site of the pain relief patch on the right side of the back.
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laboratory tests; urinalysis; chest X-ray; kidney, ureter, and bladder
X-ray; and electrocardiography were performed, and they were all
within normal limits or negative. In addition, contrast-material-
enhanced abdominal computed tomography was performed and
there were no speciﬁc ﬁndings. We considered the possibility of
herpes zoster as a cause of the patient’s dermatomal pain, although
her skin lesions were not typical of this condition. Then, skin biopsy
was performed on the one papule and revealed perivascular lym-
phocytes, neutrophils, and inﬁltration of a few eosinophils in the
dermis (Figure 2). There were no ﬁndings corresponding to herpes
zoster, such as viral inclusion bodies, epidermal necrosis, or
ballooning degeneration. The histopathological ﬁndings were not
speciﬁc and were supposed to comprise an irritation reaction
because of the pain relief patch. We thought that herpes zoster was
a cause of the patient’s dermatomal pain, but the cutaneous ﬁnd-
ings and histological examination were not indicative of herpes
zoster, and these ﬁndings could not explain the cause of pain. The
diagnosis was in doubt, so we decided to check nested PCR analysis
of VZV DNA in skin exudate. A skin exudate specimenwas obtained
by scratching the nonlesional skin of the painful dermatomes with
a needle. DNA extraction was performed by using a QIAamp DNAFigure 2 Results of histological examination showing perivascular lymphocyte,
neutrophil, and a few eosinophil inﬁltrations in the dermis (hematoxylin and eosin
stain, 100).blood mini QIAcube kit (Qiagen Inc., Hilden, Germany) according to
the manufacturer’s protocol. VZV DNA was ampliﬁed with nested
PCR technique using two primer sets derived from the gene 29
encoding the DNA binding protein (1st PCR: 5-TACGGGTCTTGCCG
GAGCTGGTAT-3 and 5-AATGCCGTGACCACCAAGTATAAT-3; 2nd
PCR: 5-TCTTTCACGGAGGCAAACAC-3 and 5-TCCAAGGCGGGTGCA-
TATCT-3). Nested ampliﬁcation product was seen with 2% agarose
gel electrophoresis and the expected 161 base pair products were
conﬁrmed in the patient’s sample (Figure 3). Finally, ZSH was
diagnosed in this patient. Treatment with famciclovir 250 mg three
times daily was administered for 7 days. The patient refused an-
algesics because they had been ineffective previously. After 7 days,
there was marked improvement in the patient’s radicular pain.
After 2 weeks, the cutaneous lesions and pain had completely
subsided without sequelae.
Discussion
ZSH refers to a condition in which pain with a dermatomal distri-
bution occurs in the absence of an antecedent rash.1 Since the
original description of “radicular pain without cutaneous rash”
observed by Widal,8 a few cases have been reported in the neuro-
logical literature. However, only one case has been reported in our
review of the dermatological literature.9 Although the true inci-
dence of ZSH is not yet known, we have frequently encountered
cases in which ZSH was suspected, and our case could offer useful
information to other dermatologists.
Although herpes zoster is generally diagnosed on a clinical basis
alone, VZV reactivation without rash requires virological conﬁr-
mation. Laboratory testing (e.g., punch biopsy, Tzanck smear, or
viral isolation in cell culture of vesicle samples), which has been
used in the diagnosis of herpes zoster, is not useful in the absence of
cutaneous lesions. Recently, it has been reported that the appro-
priate investigations to establish the diagnosis of ZSH are PCR for
VZV DNA, as well as anti-VZV IgG in CSF, and examination of PBMCs
for VZV DNA.4 In dermatological practice, blood specimens are
more commonly used than CSF for diagnosis. However, VZV DNA
has been detected in PBMCs in approximately one-ﬁfth of patients
with herpes zoster,5,6 and there is a report that VZV DNA was not
detected in PBMCs in patients with ZSH.7 Judging from these
ﬁndings, PCR for PBMCs does not provide a useful measure of VZV
in patients with ZSH.10 Therefore, the use of other specimens has
been attempted, and diagnostic methods using saliva11,12 or tear
ﬂuid13 have been reported. In addition to saliva and tear ﬂuid, skin
exudate has been used in the diagnosis of ZSH.13,14 Murakami et al13
have reported that PCR analysis in skin exudate of the auricular skin
can be a rapid and useful diagnostic tool for identiﬁcation of VZV
infection in acute peripheral facial palsy or dysphagia without
herpetic eruption. In that study, skin exudate, blood, and tear ﬂuid
were collected in the six patients in whom ZSH was retrospectively
diagnosed through elevation of serum antibody titer. VZV genomes
were detected in four of the six specimens of the auricular skin
exudate (67%), in two of the six PBMC specimens (33%), and in two
of the six tear ﬂuid specimens (33%). These results suggest that PCR
analysis of VZV DNA in skin exudate can be more useful than other
specimens for diagnosis of ZSH. Once latent VZV reactivates in the
ganglia, it migrates via the sensory nerves, and is released from the
nerve endings in the skin, forming a zosteriform rash. Thus, VZV
might be present in the nerve endings of skin epithelial cells,15 and
identiﬁed in skin exudates as in our case.
In the current case, famciclovir was prescribed and illness pro-
gression was observed. During the patient’s next visit, pain was
dramatically improved although no analgesic was given. Apart from
her dermatomal pain and PCR result, the patient’s response to
antiviral drug therapy was suggestive of herpes zoster. Randomized
Figure 3 Polymerase chain reaction results showing a positive band of 161 bases per
size representing varicella zoster virus DNA. Lane 1, molecular weight marker; Lane 2,
positive control; Lane 3, negative control; and Lane 4, positive result of the patient’s
sample.
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time to rash healing and the duration and severity of acute pain in
patients with herpes zoster who are treated within 72 hours of rash
onset.16,17 Although antiviral therapy may be considered ineffective
because of the diagnostic delay, we decided to treat the patient
with oral famciclovir. There are some reports that treatment with
antiviral drugs produces marked improvement several months af-
ter the onset of pain.18,19
Unlike previous cases of ZSH presenting with cranial nerve palsy
diagnosed by PCR analysis of skin exudates,13,14 our patient com-
plained of thoracic-distribution radicular pain and we planned to
obtain skin exudate specimens rather than PBMCs or CSF; VZV
infection was ﬁnally identiﬁed. The case in which VZV DNA was
identiﬁed in skin exudates in patients presenting with no cranial
nerve involvement has not yet been reported. We think that the
diagnosis of ZSH should always be considered in the pertinentclinical context, particularly when there is a history of chronic
radicular pain unresponsive to previous treatment. We conclude
that PCR analysis of VZV DNA in skin exudate can be more valuable
than PCR for other specimens in the diagnosis of ZSH, but in order
to assess diagnostic usefulness of PCR analysis of VZV DNA in skin
exudate of patients presenting with radicular pain, a large antero-
grade study is mandatory.References
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